ID

20356

Descrição

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 5 (Month 12) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Palavras-chave

Versões (1)
  1. 21/02/17 21/02/17 -
Transferido a

21 febbraio 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Inglês

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulários  
Concomitant Medication
Descrição

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since visit 2, were any of the non-study medications listed below taken?
Descrição

Concomitant medication

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
If yes, please indicate which of the following were taken:
Descrição

If yes, please indicate which

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1524063
ACE Inhibitors
Descrição

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since visit 2, were any ACE inhibitors taken?
Descrição

ACE Inhibitors currently taken

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
If yes, please indicate which, and total daily dose:
Descrição

If yes

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
UMLS CUI [2]
C2348070
Restricted Concomitant Medication
Descrição

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0443288
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
Descrição

Restricted medication taken

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
UMLS CUI [1,4]
C0443288
If yes, please indicate which category
Descrição

if yes

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0443288
Voltar ao início da página

Similar models

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant medication
Item
1. Since visit 2, were any of the non-study medications listed below taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Item
If yes, please indicate which of the following were taken:
integer
C2347852 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes, please indicate which
Code List
If yes, please indicate which of the following were taken:
CL Item
Parental anticoagulants (Short term use)  (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since visit 2, were any ACE inhibitors taken?
boolean
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes
Item
If yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C2348070 (UMLS CUI [2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0443288 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0443288 (UMLS CUI [1,4])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,3])
if yes
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Voltar ao início da página 

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial